Hostname: page-component-848d4c4894-jbqgn Total loading time: 0 Render date: 2024-06-21T14:14:55.888Z Has data issue: false hasContentIssue false
  • English
  • Français

A case for judicious use of risperidone and olanzapine in behavioral and psychological symptoms of dementia (BPSD)

Published online by Cambridge University Press:  05 April 2005

AJIT SHAH  and
GUK HEE SUH
AJIT SHAH
Affiliation:
West London Mental Health NHS Trust, London and Imperial College School of Medicine, London, U.K.a.k.shah@ic.ac.uk
GUK HEE SUH
Affiliation:
Hallym University College of Medicine Seoul, Koreasuhgh@chollian.net
Get access Rights & Permissions [Opens in a new window]

Extract

Behavioral and psychological signs and symptoms of dementia (BPSD) include disorders of behavior, mood, thought content and perception (Burns et al., 1990a, b, c, d; Foli and Shah, 2000). BPSD are common (Foli and Shah, 2000) and can cause distress to patients, informal carers and professionals, and lead to institutionalization and over-medication (Shah, 1999). Both non-pharmacological and pharmacological treatment strategies have been utilized to improve BPSD. Despite the recent controversy surrounding the use of olanzapine and risperidone for BPSD, a case for judicious use of these drugs is rehearsed below.

Type
For Debate
Information
International Psychogeriatrics , Volume 17 , Issue 1 , March 2005 , pp. 12 - 22
Copyright
International Psychogeriatric Association 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)